First patient in China has been dosed in the YOLT-201 clinical trial for the treatment of Hereditary ATTR-CM

The study by YolTech is a single-arm, open-label, dose-escalation clinical trial (Clinicaltrials.gov: NCT06082050). This trial's primary objectives are to ...

December 18, 2023 | Monday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
OmniAb Unveils Latest Scientific Data on OmnidAb™ Platform at 2023 Antibody Engineering Conference

OmniAb, Inc.  announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...

December 15, 2023 | Friday | News
South Korean Genomics Giant, Macrogen, Secures Strong Presence in Basel, Switzerland

  Macrogen Europe is seeking to expand within Switzerland from its foothold in Basel with its Sanger sequencing laborato...

December 13, 2023 | Wednesday | News
EnGeneIC's Novel cGranted FDA Fast-Track Designation

Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative t...

December 08, 2023 | Friday | News
IMIDomics and Bristol Myers Squibb Extend Partnership for Inflammatory Disease Research

In 2016, IMIDomics entered into a strategic partnership with BMS to harness their unique clinical and molecular database, and multidimensional analysis con...

December 07, 2023 | Thursday | News
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium ...

December 07, 2023 | Thursday | News
Momentum Biotechnologies Introduces Proteomics as Latest Service

For almost a decade, Momentum has been offering clients a wide range of early drug discovery services including high-throughput screening, hit characteriza...

November 30, 2023 | Thursday | News
Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Merck Acquires Caraway Therapeutics as Dementia Discovery Fund Facilitates Groundbreaking Move

The Dementia Discovery Fund (DDF), a SV Health Investors (SV) fund specialized in pursuing transformational therapeutic approaches for dementias including ...

November 23, 2023 | Thursday | News
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

Serina Therapeutics, Inc. (Serina), a privately held, clinical stage biotechnology company focused on developing its proprietary POZ Platform TMdrug delive...

November 20, 2023 | Monday | News
Cytiva Introduces Groundbreaking Affinity Technology for Versatile Protein Purification

Cytiva, a global leader in life sciences, introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant pro...

November 17, 2023 | Friday | News
Legend Biotech Secures Exclusive Global License for CAR-T Therapies Targeting DLL3.

The deal with Novartis seeks to advance Legend Biotech’s autologous CAR-T cell therapy candidate, LB2102, and other potential CAR-T cell therapies ...

November 14, 2023 | Tuesday | News
Sandoz Opens Antibiotic Plant in Austria, Biosimilar Center in Germany

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will signifi...

November 13, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close